Is there a place for ESWL in the treatment of complicated proximal ureteral stones?

Although recently the minimal invasive urological and endourological methods have been substantially improved, concerns remain about the optimal management of proximal ureteral stones. Even the Euro-pean Association of Urology Guidelines are not fully clear and leave the choice of treatment method to the urologist's discretion. Both extracorporeal shock wave lithotripsy (ESWL) and ureteroscopy (URS) are accepted methods of the proximal ureteral stones management. ESWL is very often used as a first– line procedure because of its minimal invasiveness. It is proper for ureteral stones in all locations, but especially suitable for proximal (lumbar) localization because URS is considered more difficult in the upper part of the ureter. Authors of the paper published in this issue of Central European Journal of Urology have discussed the impact of a double–J stent for the results of ESWL in ureteral lumbar stones [1]. A lot of predictors have been reported to influence ESWL outcome in the management of ureteral calculi [2]. One of them is a double–J stent. As the authors have pointed, there are conflicting opinions on the ESWL effects in the management of ureteral stones in pre–stent-ed patients. There is a quite popular theory that the indwelling stent creates expansion space thus facilitating effects of ESWL. On the other hand many authors stress that a stent can absorb energy of shock waves, impede their propagation and energy transmission thus lowering fragmentation rate. Also, while some suggest that catheters aid fragments passage by passive dilatation of the ureter [3] others point out that double–J stents can cause uretheral oedema, irritation and diminished peristalsis delaying clearance [4]. Results reported by Pettenati et al. show that presence of a double–J stent adversely affect the results of ESWL for stones >8 mm. The main limitation of this study is its retrospective design. However, some prospective studies have also reported that pre–stenting before ESWL does not improve the procedure results. In the recent prospective randomized trial stenting prior ESWL provided no additional advantage over in–situ ESWL. There was no statistical significant difference in stone–free rates between stented and non–stented patients with upper impacted ureteral stones measuring ≤2 cm treated with ESWL (90% vs. 86.7% respectively; p = 0.346) [5]. In another prospective randomized study pre–stenting limited stone–free rates in the ESWL management 4 to 10 mm ureteral stones (68.6% vs. 83.7% for stented and non–stented groups respectively; p = 0.026) and was responsible for higher post–ESWL morbidity …